Pediatrics
From the Journals
Juvenile dermatomyositis derails growth and pubertal development
Delayed puberty and growth failure were observed in children with juvenile dermatomyositis.
Conference Coverage
BP load predicts cardiovascular damage in children
NEW ORLEANS – The amount of time spent above the 95th blood pressure percentile is an emerging metric of pediatric hypertension control.
From the Journals
For trans children, early gender ID conversion efforts damage lifelong mental health
Exposure before age 10 years quadruples the lifetime risk of suicidal behavior.
Conference Coverage
Wrong cuff size throws off pediatric BP by 5 mm Hg
NEW ORLEANS – The study helps inform the use of a cuff that’s too big or too small when the correct sized cuff is unavailable.
Latest News
Bisphosphonates improve BMD in pediatric rheumatic disease
Children and adolescents whose chronic rheumatic disease is treated with steroids could benefit from bisphosphonate therapy to improve bone...
News
FDA approves Baqsimi nasal powder for emergency hypoglycemia treatment
It is the first glucagon therapy approved for this indication that is administrable without an injection.
Conference Coverage
Type 2 diabetes is particularly devastating in adolescents
SAN FRANCISCO – “These kids have problems you’d expect in their grandparents.” – Dr....
News
Liraglutide indication expanded to include children
The approval marks the first noninsulin drug approved for pediatric use in almost 20 years.
News
Obesity and overweight declined among lower-income kids
The reduction still leaves 29.1% of 2 to 4-year-olds in the Supplemental Nutrition Program for WIC either overweight or obese.
Opinion
Addressing the sexual and reproductive health needs of trans and gender nonconforming patients
Understanding how trans or GNC patients have sex is essential to providing comprehensive sexual and reproductive health care.
Conference Coverage
Liraglutide seems safe, effective in children already on metformin
Liraglutide seems to be safe and effective for children and adolescents with type 2 diabetes who are already on metformin therapy.